ETF Components for IBB - iShares Nasdaq Biotechnology Index Fund


Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

Holdings

Symbol Grade Price % Change Allocation
GILD B -0.45 9.77
VRTX D -0.76 8.08
AMGN D -0.76 7.32
REGN F -0.31 5.67
IQV F -0.41 3.75
ALNY D 0.33 3.32
MTD F 0.00 2.58
BIIB F -0.20 2.36
ILMN C -0.51 2.27
WAT B 0.69 2.22
UTHR C -0.06 1.70
NTRA A -1.44 1.52
INCY C -0.86 1.49
MRNA F -0.97 1.45
NBIX C -0.33 1.22
BMRN F -1.02 1.21
INSM C -0.92 1.14
TECH F 0.57 1.13
CRL D 0.45 1.07
PCVX D 0.79 1.03
SRPT F -0.70 0.99
EXEL B 0.29 0.97
MEDP F 0.00 0.89
ITCI B -0.34 0.85
RVMD B 1.24 0.80
RGEN D -0.22 0.75
HALO F -0.11 0.73
CYTK D 0.74 0.62
MDGL C 0.60 0.59
BPMC C -0.55 0.58
BRKR F -0.08 0.56
ROIV D 1.87 0.50
IONS F -0.40 0.49
RNA C -1.23 0.49
ADMA B -0.66 0.48
CRNX B -0.56 0.48
ALKS C 0.14 0.46
KRYS C -0.29 0.44
BHVN C -1.77 0.40
RARE F 0.86 0.40
CRSP D -1.88 0.40
ACLX C 0.83 0.39
AXSM B 0.48 0.38
DNLI D -0.23 0.35
BBIO F 0.86 0.34
RYTM C -0.19 0.34
AGIO C 0.61 0.32
PTCT B 0.66 0.32
XENE D 0.64 0.31
NUVL D 0.12 0.30
MRUS F 4.20 0.30
ACAD C -2.86 0.29
APLS F -2.09 0.29
FOLD F -0.21 0.29
KYMR D -0.85 0.28
VCYT B -0.23 0.28
VCEL A 1.03 0.26
TWST F -0.80 0.25
ARWR D -0.72 0.25
IOVA F -0.06 0.23
IDYA F 0.14 0.23
PTGX D 4.06 0.23
APGE F -1.37 0.21
LGND C 0.54 0.21
DYN D -1.23 0.21
GERN C 1.13 0.21
SWTX C 0.11 0.21
VERA C 2.25 0.20
EWTX C 0.27 0.20
WVE C 0.14 0.19
KROS D -0.54 0.19
FTRE D -0.73 0.19
JANX C -0.88 0.19
SRRK B -0.04 0.19
BEAM D -1.47 0.19
IMVT F 0.67 0.18
AKRO C -0.24 0.18
MNKD B -0.87 0.18
NRIX C -0.13 0.17
GPCR F -0.32 0.17
NVCR C 0.71 0.17
DVAX C 0.70 0.17
SMMT D 0.91 0.17
MIRM B -0.09 0.16
XNCR B 0.44 0.16
RXRX D -3.31 0.16
NTLA F 5.04 0.16
TARS C -0.96 0.15
BCRX D -1.23 0.15
TXG F -0.38 0.15
ARVN F 0.63 0.15
MYGN F 0.07 0.14
TVTX C 2.24 0.14
ZYME C -2.61 0.14
SNDX F -1.54 0.13
NVAX F 0.56 0.13
RCKT F -0.39 0.13
KURA F -38.59 0.12
AUPH C 2.00 0.11
CDNA D -0.27 0.11
IRON B 0.70 0.10
ARQT B 0.59 0.10
KNSA F 0.00 0.09
ETNB D -0.50 0.09
DAWN D -1.10 0.09
ELVN C -0.18 0.08
PRTA F -0.55 0.08
VIR F 0.00 0.08
SPRY C -1.33 0.08
RCUS F -0.17 0.08
ADPT C -2.90 0.08
CTKB C -1.22 0.08
CSTL D 1.34 0.08
COGT D 1.43 0.08
IRWD F -3.27 0.07
PLRX D 0.47 0.07
AVXL B 1.47 0.07
OLMA F -3.50 0.06
PACB D 2.62 0.06
CGEM F -1.67 0.06
REPL C 0.45 0.06
MRVI F -0.73 0.06
RLAY F -1.72 0.06
NUVB C 0.38 0.06
ORIC F 0.00 0.05
RGNX D 0.00 0.05
URGN F 0.96 0.05
ARCT F -2.29 0.05
YMAB F -0.14 0.05
ERAS C -1.33 0.05
HUMA F 3.74 0.05
OPK B -1.27 0.05
QTRX F 0.00 0.05
ABUS D 1.08 0.05
ANAB F 1.60 0.05
TSHA C 1.00 0.04
FLGT F 0.12 0.04
SLRN F -1.35 0.04
RVNC F 0.39 0.04
ALLO F 1.94 0.04
TRML C -0.90 0.04
VERV D -0.22 0.04
TBPH B -0.60 0.04
TERN F -0.71 0.04
ALEC F -1.10 0.04
ITOS F -1.21 0.03
AMLX C -0.57 0.03
SAGE F 2.85 0.03
VNDA C -0.82 0.03
DNA F 0.63 0.03
MLYS F -1.98 0.03
QURE D -0.79 0.03
PHAT F 4.58 0.03
VYGR F -1.12 0.03
KALV F -0.64 0.03
MXCT D -0.57 0.03
SANA F -2.37 0.03
FDMT F -4.99 0.03
MGTX C -0.17 0.03
SVRA F 1.92 0.03
OKUR D -0.94 0.02
ATAI B -2.20 0.02
ACRS B 12.12 0.02
CABA F -3.10 0.02
NAUT F 0.00 0.02
CRBU D -0.26 0.02
TNGX F -0.25 0.02
FULC F 0.17 0.02
PRME F -2.01 0.02
THRD D 1.81 0.02
BMEA F -1.11 0.02
ZNTL D -1.60 0.02
MGNX D -0.30 0.02
AVIR F 0.47 0.02
EDIT F -1.24 0.02
OVID D -2.88 0.01
BLUE F -2.77 0.01
CHRS D -5.47 0.01
PGEN F 0.05 0.01
VTYX F 0.00 0.01
LYEL F 0.04 0.01
MRNS F -1.13 0.00
ALXO F 0.83 0.00
RAPT F -2.80 0.00

Recent News for iShares Nasdaq Biotechnology Index Fund & its Holdings

Date Stock Title
Nov 21 KURA Kura Oncology Slams The Door On Its Takeover Narrative, And Shares Collapse 26%
Nov 21 TECH Temu Parent PDD Stock Tumbles After Q3 Profit Miss, Company Cites Intensified Competition and External Challenges
Nov 21 TECH How To Earn $500 A Month From Intuit Stock Ahead Of Q1 Earnings
Nov 21 HUMA Humacyte Clinical Results Highlighting Benefit of the ATEV™ in the Repair of Civilian and Military Arterial Injuries Published in JAMA Surgery
Nov 21 NVCR Novocure Data at 2024 SNO Annual Meeting Highlights Product Innovation and Real-World Evidence for Tumor Treating Fields (TTFields) Therapy in Glioblastoma
Nov 21 NVCR FDA Approves Novocure’s Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma
Nov 21 KURA Kura Oncology partners Kyowa Kirin to advance AML treatment
Nov 21 TECH Tesla Registrations Drop By Over 20% In October In EU, Possibly Hindering Its 2024 Global EV Delivery Target
Nov 21 TECH SpaceX CEO Elon Musk Reveals Technical Glitch That Led Company To Drop Key Objective Of Starship's 6th Test Flight
Nov 21 TECH Ray Dalio Says Pro-Trump Tech Companies Stand To Gain As Focus Shifts To Deregulation: Here's How Investors Should Brace For Impact
Nov 21 TECH SafeRent Settles $2.3M Discrimination Lawsuit Over Alleged AI Screening Bias Against Low-Income Renters
Nov 21 TECH Google's 'Unlawful Behavior' Stifles Market Entry For Rivals: DOJ Says Alphabet Must Sell Chrome To End Search Monopoly
Nov 21 TECH Tesla Now Allows Users To Report Snow Accumulation, Blocked Stalls And Other Supercharger Issues Ahead Of Winter
Nov 21 TECH Why SpaceX Opted For Standard Starship Landing Over Elon Musk's Innovative 'Chopsticks' Technique
Nov 21 TECH Ford's JV Battery Plant In Kentucky Faces Unionization As 'Supermajority' Of Workers Sign Union Authorization Cards, Says UAW
Nov 21 TECH Nvidia's Blackwell Set To Outpace Hopper? Here's What CEO Jensen Huang Predicts For 2025
Nov 21 TECH Elon Musk's Neuralink Gets Green Light To Launch Brain Chip Trial In Canada: 'Recruitment Is Now Open'
Nov 21 TECH Nvidia CEO Jensen Huang Says The Present Time Is 'The Beginnings Of Two Fundamental Shifts In Computing' As Blackwell Powers Explosive AI Demand
Nov 21 CRSP CRISPR Therapeutics AG (CRSP) Jefferies London Healthcare Conference (Transcript)
Nov 21 TECH Nvidia Stock Holding Up Better Than Gary Black's Expectations Amid Blackwell Chip Delays And Q4 Whisper Number Miss: Here's Why
The investment seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index contains securities of NASDAQ® listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by The NASDAQ OMX Group, Inc. The fund is non-diversified.
Exchange Traded Fund ETF Stock Market Index Biotechnology Pharmaceutical Nasdaq Composite Index Industry Classification Nasdaq Biotechnology Index
Back to the Main IBB Page...